Stephanie Okey's Net Worth
$1.98 Million
Who is Stephanie Okey?
Stephanie Okey has an estimated net worth of $1.98 Million. This is based on reported shares across multiple companies, which include Crinetics Pharmaceuticals, Inc., ALBIREO PHARMA, INC., PTC THERAPEUTICS, INC., and Catalent, Inc..
SEC CIK
Stephanie Okey's CIK is 0001742616
Past Insider Trading and Trends
2023 was Stephanie Okey's most active year for acquiring shares with 6 total transactions. Stephanie Okey's most active month to acquire stocks was the month of May. 2023 was Stephanie Okey's most active year for disposing of shares, totalling 6 transactions. Stephanie Okey's most active month to dispose stocks was the month of February. 2024 saw Stephanie Okey paying a total of $320,075.00 for 64,900 shares, this is the most they've acquired in one year. In 2024 Stephanie Okey cashed out on 17,500 shares for a total of $811,650.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $50.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +56.67% | 3.4K |
—
|
—
| 9.4K |
Jun 7
| |||
Form 4
|
—
|
0
|
$32.34 | -$491,575.00 | 6K |
Mar 28
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALBIREO PHARMA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PTC THERAPEUTICS, INC. (PTCT) Snapshot price: $31.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +68.18% | 4K |
—
|
—
| 9.87K |
Feb 15
| |||
Form 4
| +214.25% | 4K |
—
|
—
| 5.87K |
Jan 5
| |||
Form 4
| -55.15% | -2.30K |
$51.62 | -$118,521.82 | 1.87K |
Aug 9
| |||
Form 4
| +332.29% | 3.2K |
—
|
—
| 4.16K |
Jan 7
| |||
Form 4
| -63.15% | -1.65K |
$40.06 | -$66,094.05 | 963 |
Aug 13
| |||
Form 4
| +171.34% | 1.65K |
—
|
—
| 2.61K |
Jan 6
| |||
Form 4
| -41.64% | -687.00 |
$62.52 | -$42,953.99 | 963 |
Dec 8
| |||
Form 4
|
∞
| 1.65K |
—
|
—
| 1.65K |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Catalent, Inc. (CTLT) Snapshot price: $60.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +58.49% | 4.66K |
—
|
—
| 12.63K |
Oct 30
| |||
Form 4
| +714.30% | 6.99K |
—
|
—
| 7.97K |
Oct 27
| |||
Form 4
|
∞
| 979 |
—
|
—
| 979 |
Aug 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||